Mainz BioMed N.V. | WebDisclosure

Basculer en Français

9478	Companies
185488	Keywords
117863	Articles
99343	Press releases

Home
Companies
Mainz BioMed N.V.

PRESS RELEASE

published on 04/28/2025 at 14:04, 7 months 7 days ago

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
Mainz Biomed provides Q1 2025 corporate update on FDA premarket approval path, including study enrollment, partnership with Liquid Biosciences and labor team w ag, and product launches. CEO Guido Baechler comments on progress

FDA ColoAlert Mainz Biomed Q1 2025 Premarket Approval
BRIEF

published on 04/01/2025 at 14:06, 8 months 4 days ago

Mainz Biomed Releases 2024 Financial Results

Financial Results Strategic Partnerships Nasdaq Compliance Mainz Biomed Colorectal Cancer Screening
BRIEF

published on 04/01/2025 at 14:06, 8 months 4 days ago

Mainz Biomed publie ses résultats financiers pour 2024

Résultats Financiers Partenariats Stratégiques Mayence Biomed Conformité NASDAQ Dépistage Du Cancer Colorectal
PRESS RELEASE

published on 04/01/2025 at 14:01, 8 months 4 days ago

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
Mainz Biomed N.V. reports 2024 financial results, highlights lab network revenue growth by 33% and strategic partnerships, updates on corporate developments for early 2025

Strategic Partnerships Corporate Update Mainz Biomed N.V. 2024 Financial Results Lab Network Revenue
BRIEF

published on 03/27/2025 at 14:06, 8 months 9 days ago

Mainz Biomed lance l'étude clinique eAArly DETECT 2

Cancer Colorectal Mayence Biomed Étude Clinique Biomarqueurs D'ARNm Détection Des Précancéreux
BRIEF

published on 03/27/2025 at 14:06, 8 months 9 days ago

Mainz Biomed Launches eAArly DETECT 2 Clinical Study

Clinical Study Mainz Biomed Colorectal Cancer MRNA Biomarkers Precancerous Detection
PRESS RELEASE

published on 03/27/2025 at 14:01, 8 months 9 days ago

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
Mainz Biomed enrolls the first patient in the eAArly DETECT 2 Clinical Study to validate industry-leading results for detecting advanced precancerous lesions. Top-line results expected in Q4 2025

Clinical Study Early Detection Mainz Biomed EAArly DETECT 2 Advanced Precancerous Lesions
BRIEF

published on 03/13/2025 at 14:06, 8 months 23 days ago

Mainz Biomed et Liquid Biosciences dévoilent de nouveaux biomarqueurs d'ARNm pour la détection du cancer du pancréas

Mayence Biomed Biomarqueurs D'ARNm Cancer Du Pancréas Biosciences Liquides Détection Par Test Sanguin
BRIEF

published on 03/13/2025 at 14:06, 8 months 23 days ago

Mainz Biomed and Liquid Biosciences Unveil Novel mRNA Biomarkers for Pancreatic Cancer Detection

Mainz Biomed MRNA Biomarkers Pancreatic Cancer Liquid Biosciences Blood Test Detection
PRESS RELEASE

published on 03/13/2025 at 14:01, 8 months 23 days ago

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Mainz Biomed and Liquid Biosciences make groundbreaking discovery of mRNA biomarkers for blood-based detection of pancreatic cancer, achieving transformative sensitivity of 95% and specificity of 98%

Mainz Biomed MRNA Biomarkers Pancreatic Cancer Liquid Biosciences Blood-based Detection

Accesswire

Published on 12/05/2025 at 16:00, 11 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 26 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 26 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 36 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 46 minutes ago

Usha Resources Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 16:00, 11 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 11 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 11 minutes ago

Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 16:00, 11 minutes ago

Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 15:47, 23 minutes ago

Form 8.3 - The Vanguard Group, Inc.: NCC Group plc

Les Echos

Published on 12/05/2025 at 15:10, 1 hour ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 2 hours 12 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 26 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 26 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE